DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Prefilled Syringes Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
Prefilled syringes are gaining acceptance in the market as drug delivery systems designed for injectable drugs. They are generally preferred for parenteral administration of various drugs and are used mainly for the treatment of chronic diseases where patients have to administer medication themselves, several times a week. The key drivers for the growth of this market are rising incidences of chronic diseases that require frequent drug administration, growing home-based healthcare market, increasing adoption of injectable drugs, benefits over syringe packaging systems and growing demand for point-of-care drug administration.
The major restraints for this market are the presence of alternative drug delivery means, the cost associated with the manufacturing of prefilled syringes, storage problem for these syringes and stringent regulations set by government authorities. Prefilled syringes offer several advantages over conventional vials to healthcare providers, drug manufacturers and patients such as accurate dosing, simple operation and lower risk of contamination. Moreover, technological advancement, new innovations and meeting the unmet demand for these syringes are the key opportunities for the foreseeable future of the prefilled syringes market.
Europe holds the largest market share in the prefilled syringes market due to the high rate of adoption in this region. The North American market is also forecast to grow at a high CAGR due to prefilled syringes being the most preferred devices for drug delivery and the rising demand from the patients who need home-based healthcare treatment.
- Becton, Dickinson & Company
- Baxter International
- Nipro Corporation
For more information about this report visit http://www.researchandmarkets.com/research/5c9jh9/world_prefilled.